← Back to headlines
ImmunityBio Investors Offered Opportunity to Lead Securities Fraud Lawsuit
Investors in ImmunityBio, Inc. (IBRX) are being presented with an opportunity to lead a securities fraud class action lawsuit against the company.
6 Apr, 22:06 — 6 Apr, 22:06
